These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25225343)

  • 21. Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice.
    Ji B; Chauffour A; Robert J; Lefrançois S; Jarlier V
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3737-9. PubMed ID: 17664316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To Buruli or not to Buruli.
    Ho L; Cohn J; Comte E
    Trop Doct; 2013 Apr; 43(2):92. PubMed ID: 23796682
    [No Abstract]   [Full Text] [Related]  

  • 23. Case Report: A New Mycobacterium ulcerans Genotype Causing Buruli Ulcer in Côte d'Ivoire.
    Bahadoran P; Hammoudi N; Gaudart A; Saad J; Di Filippo Y; Drancourt M; Ruimy R
    Am J Trop Med Hyg; 2021 Apr; 104(5):1782-1783. PubMed ID: 33819173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update.
    O'Brien DP; Jenkin G; Buntine J; Steffen CM; McDonald A; Horne S; Friedman ND; Athan E; Hughes A; Callan PP; Johnson PD
    Med J Aust; 2014 Mar; 200(5):267-70. PubMed ID: 24641151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.
    Etuaful S; Carbonnelle B; Grosset J; Lucas S; Horsfield C; Phillips R; Evans M; Ofori-Adjei D; Klustse E; Owusu-Boateng J; Amedofu GK; Awuah P; Ampadu E; Amofah G; Asiedu K; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3182-6. PubMed ID: 16048922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined local and vaginal therapy in Buruli ulcer].
    Milánkovits M
    Orv Hetil; 2010 Aug; 151(35):1434-5. PubMed ID: 20824910
    [No Abstract]   [Full Text] [Related]  

  • 27. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
    Friedman ND; Athan E; Walton AL; O'Brien DP
    Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans.
    Warryn L; Pluschke G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0087021. PubMed ID: 34662181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease.
    Sarfo FS; Phillips R; Asiedu K; Ampadu E; Bobi N; Adentwe E; Lartey A; Tetteh I; Wansbrough-Jones M
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3678-85. PubMed ID: 20566765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans.
    Sarfo FS; Phillips RO; Ampadu E; Sarpong F; Adentwe E; Wansbrough-Jones M
    Clin Vaccine Immunol; 2009 Jan; 16(1):61-5. PubMed ID: 19005025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
    Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
    Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
    Velink A; Woolley RJ; Phillips RO; Abass KM; van der Werf TS; Agumah E; de Zeeuw J; Klis S; Stienstra Y
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005261. PubMed ID: 28033343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buruli ulcer in an 18-day-old baby.
    Kiiza AM; Wood PB
    Trop Doct; 2012 Jan; 42(1):48. PubMed ID: 22080481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series.
    Jerjen R; Moodley A; Sinclair R
    Australas J Dermatol; 2020 Nov; 61(4):376-377. PubMed ID: 32578188
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin.
    Dossou AD; Sopoh GE; Johnson CR; Barogui YT; Affolabi D; Anagonou SY; Zohoun T; Portaels F; Asiedu K
    Med J Aust; 2008 Nov; 189(9):532-3. PubMed ID: 18976206
    [No Abstract]   [Full Text] [Related]  

  • 37. Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
    Almeida D; Converse PJ; Ahmad Z; Dooley KE; Nuermberger EL; Grosset JH
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e933. PubMed ID: 21245920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should antibiotics be given for Buruli ulcer?
    Johnson PD
    Lancet; 2010 Feb; 375(9715):618-9. PubMed ID: 20137806
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.
    Sopoh GE; Dossou AD; Brun LV; Barogui YT; Houézo JG; Affolabi D; Anagonou SY; Johnson RC; Kestens L; Portaels F
    Am J Trop Med Hyg; 2010 Aug; 83(2):307-13. PubMed ID: 20682873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan.
    Sugawara M; Ishii N; Nakanaga K; Suzuki K; Umebayashi Y; Makigami K; Aihara M
    J Dermatol; 2015 Jun; 42(6):588-95. PubMed ID: 25809502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.